RxDoctor Payments DataLook up a doctor →

Rajesh Sharma

Interventional Cardiology · Westminster, CONPI 1033116272

Payments from drug & device makers

$116,936in general payments, 2019–2025

Across 1,334 payments — averaging $87.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$29K
  • Medtronic$26K
  • Esperion Therapeutics, Inc.$13K
  • Penumbra, Inc.$8K
  • Abbott$6K
  • Angiodynamics, Inc.$4K
  • plus $30K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen61$29,473
Medtronic(3 entities)153$25,639
Esperion Therapeutics, Inc.38$13,459
Penumbra, Inc.27$7,825
Abbott88$6,359
Angiodynamics, Inc.8$4,198
Shockwave Medical, Inc28$2,931
Boston Scientific46$2,341
Bard Peripheral Vascular, Inc.37$1,905
Actelion Pharmaceuticals US, Inc.94$1,709
Terumo Medical Corporation7$1,236
Johnson & Johnson74$1,191
Philips North America LLC25$1,121
Novartis58$1,040
Heartflow, Inc.26$937
Boehringer Ingelheim39$935
Bayer39$930
Biotronik Inc.16$912
E.r. Squibb & Sons, L.L.C.41$848
Inari Medical, Inc.23$817
AstraZeneca37$804
Impulse Dynamics (USA) Inc.14$723
Pfizer40$710
Sanofi-aventis U.S. LLC29$609
Edwards Lifesciences8$563
Cardiovascular Systems Inc.11$549
W. L. Gore & Associates, Inc.6$531
Kestra Medical Technology Services, Inc.17$474
Merck21$472
Alnylam Pharmaceuticals Inc.13$409
Novo Nordisk20$384
Cvrx, Inc.15$342
Endologix LLC5$306
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)17$273
Tactile Systems Technology Inc8$266
Amarin Pharma, Inc.15$262
Nevro Corp.1$250
Scpharmaceuticals Inc.15$235
Biocardia, Inc.1$205
Venclose Inc.5$205
Lundbeck LLC11$204
Regeneron Healthcare Solutions, Inc.9$203
United Therapeutics Corporation8$185
Cordis US CORP.9$166
Kowa Pharmaceuticals America, Inc.8$140
ZOLL Respicardia, Inc.1$129
Cardinal Health 200 LLC2$123
Bridgebio Pharma, Inc.4$122
Abiomed5$121
Kiniksa Pharmaceuticals International, PLC5$99
Arbor Pharmaceuticals, Inc.5$97
Siemens Medical Solutions USA, Inc.1$91
Daiichi Sankyo Inc.5$81
Baxter Healthcare3$72
Kiniksa Pharmaceuticals, Ltd.3$56
Veryan Medical Incorporated1$54
BD1$52
Irhythm Technologies, Inc.1$46
Lexicon Pharmaceuticals, Inc.3$44
Cleerly, Inc.2$39

How this compares

$116,936 in reported general payments places this provider in the 75th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado

Medicare billing

Part B allowed, 2024
$331,782
Medicare patients
570
Services billed
3,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Westminster

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →